Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDAMA Pediatric Incentives Should Apply To Biologics, PhRMA Testifies

Executive Summary

FDA may be willing to discuss new incentives for manufacturers to conduct pediatric studies on products not covered under the FDA Modernization Act's pediatric exclusivity rule, FDA Commissioner Henney said Oct. 21 at a hearing of the Senate Health, Education, Labor & Pensions Committee.

You may also be interested in...



Senate Hearings On IoM Medical Errors Report Planned For Early 2000

Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.

Senate Hearings On IoM Medical Errors Report Planned For Early 2000

Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.

Epogen Pediatric Use & Neupogen Cable Ads Expand Major Amgen Franchises

New cable TV ads to identify new cancer patients for Neupogen and a recently approved expansion of Epogen indications to the pediatric population are examples of Amgen's increasing efforts to support its flagship franchises.

Related Content

UsernamePublicRestriction

Register

PS035044

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel